ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models

• 主要な著者: Linxi Zhu (著者), Qingxin Mu (著者), Jesse Yu (著者), James I. Griffin (著者), Xiaolin Xu (著者), Rodney J. Y. Ho (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2021-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Despite the availability of molecularly targeted treatments such as antibodies and small molecules for human epidermal growth factor receptor 2 (HER2), hormone receptor (HR), and programmed death-ligand 1 (PD-L1), limited treatment options are available for advanced metastatic breast cancer (MBC), w...